NCT05555108

Brief Summary

The main aim of this study is to test the efficacy of a Compassive Acceptance Intervention protocol (developed by the research team) for Chronic Insomnia in comparison with the standard treatment (CBT-I).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 29, 2021

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 30, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 26, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2024

Completed
Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

3.3 years

First QC Date

May 30, 2022

Last Update Submit

August 29, 2025

Conditions

Keywords

Chronic InsomniaCBT-IACTCompassion

Outcome Measures

Primary Outcomes (1)

  • Change in insomnia severity scores

    Insomnia severity assessed by the Insomnia Severity Index (ISI). The ISI is a 7-item self-report questionnaire that evaluates the nature, severity, and impact of insomnia. Scores range from 0 to 28 points with higher scores indicating more severe insomnia symptoms.

    Baseline (2 weeks prior the start of treatment), post-treatment (2 weeks after the 10th session - treatment completion), 3 months after treatment completion, 6 months after treatment completion

Secondary Outcomes (11)

  • Change in pre-sleep arousal scores

    Baseline (2 weeks prior the start of treatment), post-treatment (2 weeks after the 10th session - treatment completion), 3 months after treatment completion, 6 months after treatment completion

  • Change in sleep effort scores

    Baseline (2 weeks prior the start of treatment), post-treatment (2 weeks after the 10th session - treatment completion), 3 months after treatment completion, 6 months after treatment completion

  • Change in dysfunctional beliefs and attitudes about sleep scores

    Baseline (2 weeks prior the start of treatment), post-treatment (2 weeks after the 10th session - treatment completion), 3 months after treatment completion, 6 months after treatment completion

  • Change in anxiety and depression symptoms scores

    Baseline (2 weeks prior the start of treatment), post-treatment (2 weeks after the 10th session - treatment completion), 3 months after treatment completion, 6 months after treatment completion

  • Change in positive and negative affect scores

    Baseline (2 weeks prior the start of treatment), post-treatment (2 weeks after the 10th session - treatment completion), 3 months after treatment completion, 6 months after treatment completion

  • +6 more secondary outcomes

Study Arms (2)

ACTCOM-I Intervention

EXPERIMENTAL
Behavioral: ACTCOM-I Intervention

Standard CBT-I Intervention

ACTIVE COMPARATOR
Behavioral: Standard CBT-I Intervention

Interventions

ACTCOM-I s an individual treatment protocol based on Acceptance and Commitment Therapy (ACT) with targeted behavioral components for insomnia treatment and a specific focus on selfcompassion as a protector for sleep disturbance.

ACTCOM-I Intervention

Standard CBT-I treatment for chronic insomnia. Treatment protocol adapted from Morin's protocol (1993)

Standard CBT-I Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Insomnia Diagnosis (ICSD-3; DSM-5)

You may not qualify if:

  • Comorbidity with severe psychiatric/psychological disorder (e.g. severe depression; psychotic disorder)
  • Comorbidity with other untreated sleep disorder
  • Altered Sleep patterns due to factors different from insomnia (e.g. shift-work; pregnancy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Medicina do Sono do Centro Hospitalar e Universitário de Coimbra

Coimbra, Portugal

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD fellowship at Center for Research in Neuropsychology and Cognitive Bebavioral Intervention (CINEICC)

Study Record Dates

First Submitted

May 30, 2022

First Posted

September 26, 2022

Study Start

January 29, 2021

Primary Completion

May 13, 2024

Study Completion

May 13, 2024

Last Updated

September 5, 2025

Record last verified: 2025-08

Locations